Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,123 across all filing types
Latest filing 2025-05-30 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
CHANGE OF NON-EXECUTIVE DIRECTOR AND CHAIRMAN OF RISK MANAGEMENT AND INTERNAL CONTROL COMMITTEE
Board/Management Information Classification · 1% confidence The document is an official company announcement detailing the resignation of one non-executive director and the appointment of another, along with committee roles and biographies. This is a direct announcement of changes in the board of directors and senior management, which matches the definition of Board/Management Information.
2025-05-30 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a ‘Next Day Disclosure Return’ (Form FF305) filed under the HKEX Listing Rules detailing changes in issued shares and treasury shares, specifically multiple on-market repurchases for cancellation by CMBC Capital Holdings Limited. It provides the number of shares repurchased, prices, dates and confirms adherence to the repurchase mandate. This is a direct report of the company buying back its own shares, matching the definition of “Transaction in Own Shares” (POS).
2025-05-29 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) filed by CMBC Capital Holdings Limited under Hong Kong Exchange rules, detailing changes in issued shares, treasury shares, and on‐market share repurchases and cancellations. It is specifically a report of the company buying back its own shares. This matches the definition of “Transaction in Own Shares” (code POS).
2025-05-28 English
DISCLOSEABLE TRANSACTION IN RELATION TO ACQUISITION OF CONVERTIBLE SECURITIES
Regulatory Filings Classification · 1% confidence The document is a corporate announcement filed on the Hong Kong Exchange under the Listing Rules. It details a “disclosable transaction” (acquisition of convertible securities) by CMBC Capital Holdings, outlining transaction terms, Listing Rule implications, principal terms, and definitions. It is not a full annual/interim report, earnings release, proxy statement, share issuance, dividend notice, or management change filing. Rather, it is a regulatory announcement required by the Stock Exchange for a significant transaction by the issuer. This aligns with our fallback “Regulatory Filings” category (RNS).
2025-05-27 English
Announcement of Allotment Results
Share Issue/Capital Change Classification · 1% confidence The document is an official Hong Kong Stock Exchange announcement detailing the global offering of new H shares by PegBio Co., Ltd., including final offer price, number of shares issued in public and international tranches, allotment results, cornerstone investor allocations, and lock-up undertakings. This clearly constitutes an announcement of a new share issue/capital change rather than a full prospectus or another report type. Therefore, it best fits the “Share Issue/Capital Change” category.
2025-05-26 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is the Hong Kong Stock Exchange FF305 “Next Day Disclosure Return” showing detailed changes in issued shares and treasury shares, including on-market repurchases and a repurchase report under Main Board Rule 10.06/GEM Rule 13.13. It is not an earnings or annual report but a regulatory disclosure of the company’s own share buybacks and treasury share movements. This falls squarely under “Transaction in Own Shares” (share repurchase/issuance).
2025-05-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.